GlobeNewswire 11/9/2021 BioNTech Announces Third Quarter 2021 Financial Results and Corporate Update
GlobeNewswire 11/9/2021 Bolt Biotherapeutics Reports Third Quarter 2021 Financial Results and Provides Business Highlights
GlobeNewswire 11/4/2021 Genmab Improves its 2021 Financial Guidance
GlobeNewswire 11/1/2021 BioNTech to Present New Clinical Data from First-in-Class CAR-T Program BNT211 in Late-breaking Sess...
GlobeNewswire 10/29/2021 Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Chil...
GlobeNewswire 10/28/2021 Pfizer And BioNTech to Provide U.S. Government an Additional 50 Million Pediatric Doses of COVID-19 ...
GlobeNewswire 10/27/2021 BioNTech to Report Third Quarter Financial Results and Operational Update on November 9, 2021
GlobeNewswire 10/27/2021 FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTec...
GlobeNewswire 10/26/2021 BioNTech Plans to Initiate the Construction of an mRNA Vaccine Manufacturing Facility in Africa in ...
GlobeNewswire 10/21/2021 Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COV...
GlobeNewswire 10/19/2021 Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Third Quarter of 2021
GlobeNewswire 10/4/2021 Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the European Union
GlobeNewswire 10/1/2021 BioNTech to Present New Clinical and Preclinical Data Across Multiple Immuno-Oncology Programs at 36...
GlobeNewswire 10/1/2021 BioNTech Expands Clinical Oncology Portfolio with First Patient Dosed in Phase 2 Trial of mRNA-based...
GlobeNewswire 9/22/2021 Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccin...
GlobeNewswire 9/21/2021 Capital Increase in Genmab as a Result of Employee Warrant Exercise
GlobeNewswire 9/20/2021 Genmab and Seagen Announce FDA Accelerated Approval for TIVDAK™ (tisotumab vedotin-tftv) in Previous...
GlobeNewswire 9/20/2021 Pfizer and BioNTech Announce Positive Topline Results from Pivotal Trial of COVID-19 Vaccine in Chil...
GlobeNewswire 9/18/2021 FDA Advisory Committee Votes Unanimously in Favor of COMIRNATY® Booster for Emergency Use in People ...
GlobeNewswire 8/27/2021 Joint Communiqué: BioNTech Evaluates mRNA Vaccine Manufacturing Solutions in Rwanda and Senegal to I...
GlobeNewswire 8/26/2021 Pfizer and BioNTech Announce Collaboration with Brazil’s Eurofarma to Manufacture COVID-19 Vaccine D...
GlobeNewswire 8/25/2021 Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S...
GlobeNewswire 8/23/2021 Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years...
GlobeNewswire 8/16/2021 Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID...
GlobeNewswire 8/12/2021 Bolt Biotherapeutics Reports Second Quarter 2021 Financial Results and Provides Business Highlights